The global perennial allergic rhinitis drug market is anticipated to grow at a significant CAGR of 4.0% during the forecast period 2022-2028. The increased awareness of allergic responses around the globe is likely to fuel the growth of the perennial allergic rhinitis market. Additionally, the high quality of drugs and nasal sprays supplied by manufacturers for the treatment of chronic allergic rhinitis is predicted to fuel the growth of the market.

The global soft filler market is anticipated to grow at a considerable CAGR of 9.7% during the forecast period (2022-2028). The increasing demand for minimally invasive aesthetic procedures, particularly in developed countries, is driving market growth. Furthermore, product development that provides high patient satisfaction will have a positive impact on product demand during the forecast period. The Food and Drug Administration (FDA) of the US had approved a large number of products designed for specific facial areas, allowing dermatologists to provide targeted treatment to consumers. 

The global incretin-based drugs market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). Increased research activity, government initiatives to promote disease awareness, and research grants are primary factors that are expected to fuel the global incretin-based drug market’s growth over the forecast period. Furthermore, rising government spending in R&D activities, as well as new product releases by numerous prominent companies, are expected to further propel the diabetes medicines market.

The global post polycythemia vera myelofibrosis (PPV MF) market is anticipated to grow at a considerable CAGR of 9.1% during the forecast period (2022-2028). The increasing prevalence of chronic blood disorders is acting as the prime factor impacting the growth. As per the information provided by the Centers for Disease Control and Prevention in 2019, sickle cell disease is a blood disorder that affects more than 100,000 people in the US. Furthermore, next-generation sequencing (NGS) has identified multiple somatic mutations in MPNs and has contributed substantially to our understanding of disease pathogenesis, highlighting the role of clonal evolution in disease progression. Moreover, disease prognostication has expanded from encompassing only clinical decision-making to including genomics in prognostic scoring systems. Thus, these are the above factors mentioned which will further drive the PPV MF market.

The global parenteral nutrition market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Rising cases of metabolic disorders coupled with chronic diseases are one of the prominent factors boosting the growth of the parenteral nutrition market. As per the information provided in 2020 by the Centers for Disease Control (CDC) which highlighted the fact that diabetes has risen to an estimated 34.2 million. Additionally, Diabetes is increasing at an alarming rate in the US. Furthermore, the increasing temper of malnourishment around the globe, and the growing amount of the aging population will further boost the market. Moreover, overall concern for malnutrition and the unfit lifestyle of people will amplify the market growth.

The global Guillain barre syndrome treatment market is anticipated to grow at a significant CAGR of 5.2% during the forecast period 2022-2028. As per the information provided by the United Nations, in 2020, there are an estimated 727 million persons aged 65 years or over across. Additionally, this number is projected to be more than double by 2050, reaching over 1.5 billion persons. So, the increasing elderly population, which leads to the pervasiveness of immunological illnesses is one of the primary factors driving the expansion of the guillain barre syndrome market. 

The global smart scales Market is anticipated to grow at a considerable CAGR of 12.5% during the forecast period (2022-2028). Continuous product innovations in smart scales have led to increased features such as pregnancy-mode which has fueled consumer demand for smart scales products. Advanced Pregnancy-mode feature is one of the important promising trends in the smart scales market. This feature supports mothers by providing an efficient track of their health parameters and provides information about the progress of a pregnancy. Along with tracking of weight and body composition, these scales can also be used after pregnancy and to track baby’s growth. 

The global nasal polyposis drug market is anticipated to grow at a significant CAGR of 6.5% during the forecast period 2022-2028. The rising frequency of different malignancies and immunological illnesses, and the growing global elderly population, are two main factors driving the market's growth. Moreover, the rise in government initiatives along with new product launches by major players in the industry is propelling the growth of the market. For instance, in August 2021, Medtronic PLC announced that it had entered into a definitive agreement with Intersect ENT Inc. in which Medtronic will acquire it for approximately $1.1 billion. 

The global BPO market is anticipated to grow at a considerable CAGR of 7.8 % during the forecast period (2022-2028). Rapidly rising adoption of various advance and new technologies such as Robotic Process Automation (RPA) and cloud computing by the market players is major factor which is bolstering the growth of the market. Cloud computing uses a network of internet-connected, remote services to manage, store, and process data. It supports BPO providers in increasing the speed of production, gaining greater quality control, and reducing costs.

The global armored vehicles market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2022-2028). One of the crucial factors that have been boosting the market growth is the growing military activities between countries for strengthening the security of the nations. Such military collaboration has been increased in the past few years as the tensions between the countries have risen. It has also increased the sales of armored vehicles by exchanging the new technology, and weaponry between the countries. For instance, in January 2022, Australia purchased 120 tanks and other armored vehicles from the US is $2.58 billion.